1. Home
  2. GEO vs VKTX Comparison

GEO vs VKTX Comparison

Compare GEO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geo Group Inc (The) REIT

GEO

Geo Group Inc (The) REIT

HOLD

Current Price

$30.88

Market Cap

4.0B

ML Signal

HOLD

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$34.85

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEO
VKTX
Founded
1984
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.4B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
GEO
VKTX
Price
$30.88
$34.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$39.67
$95.86
AVG Volume (30 Days)
1.8M
2.4M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
727.27
N/A
EPS
0.29
N/A
Revenue
$2,263,420,000.00
N/A
Revenue This Year
$13.74
N/A
Revenue Next Year
$9.99
N/A
P/E Ratio
$107.52
N/A
Revenue Growth
3.85
N/A
52 Week Low
$12.51
$22.96
52 Week High
$32.25
$43.15

Technical Indicators

Market Signals
Indicator
GEO
VKTX
Relative Strength Index (RSI) 62.29 44.70
Support Level $28.74 $34.03
Resistance Level $32.25 $36.77
Average True Range (ATR) 0.98 2.05
MACD -0.10 -0.66
Stochastic Oscillator 64.11 3.75

Price Performance

Historical Comparison
GEO
VKTX

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services. The company operates in U.S, Australia and South Africa.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: